Carney complex: The first 20 years

Current Opinion in Oncology

Volumn 19, Issue 1, 2007, Pages 24-29

  Boikos, Sosipatros A ^a   Stratakis, Constantine A ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Acromegaly; Adrenal hyperplasia; Cushing syndrome; Multiple endocrine neoplasias; Pituitary tumors; PRKAR1A

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; KETOCONAZOLE; MESSENGER RNA; MITOTANE; SOMATOSTATIN DERIVATIVE;

ADRENALECTOMY; CARNEY COMPLEX; DOMINANT INHERITANCE; DRUG DESIGN; DRUG TARGETING; EARLY DIAGNOSIS; ENDOCRINE TUMOR; ENZYME ACTIVITY; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; HUMAN; NONSENSE MUTATION; PATHOGENESIS; PRIORITY JOURNAL; PRKAR1A GENE; PROGNOSIS; REVIEW; STOP CODON;

ACROMEGALY; ADRENAL HYPERPLASIA, CONGENITAL; CUSHING SYNDROME; CYCLIC AMP-DEPENDENT PROTEIN KINASES; HUMANS; MULTIPLE ENDOCRINE NEOPLASIA; MUTATION; MYXOMA; PIGMENTATION DISORDERS; PITUITARY NEOPLASMS;

EID: 33845360697     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/CCO.0b013e32801195eb     Document Type: Review

References (39)

1. Rosenzweig JL, Lawrence DA, Vogel DL, et al. Adrenocorticotropin- independent hypercortisolemia and testicular tumors in a patient with a pituitary tumor and gigantism. J Clin Endocrinol Metab 1982; 55:421-427.
2. Bain F. Carney complex [letter to editor]. Mayo Clin Proc 1986; 61:508.
3. Stratakis CA. Genetics of Peutz-Jeghers syndrome, Carney complex and other familial lentiginoses. Horm Res 2000; 54:334-343.
4. Stergiopoulos SG, Stratakis CA. Human tumors associated with Carney complex and germline PRKAR1A mutations: a protein kinase A disease. FEBS Lett 2003; 546:59-64.
5. Boikos SA, Stratakis CA. Carney complex: pathology and molecular genetics. Neuroendocrinology 2006; 83:189-199.
6. Sandrini F, Stratakis CA. Clinical and molecular genetics of Carney complex. Mol Genet Metab 2003; 78:83-92.
7. Carney JA, Young WF. Primary pigmented nodular adrenocortical disease and its associated conditions. Endocrinologist 1992; 2:6-21.
8. Stratakis CA, Kirschner LS, Carney JA. Carney complex: diagnosis and management of the complex of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas. Am J Med Genet 1998; 80:183-185.
9. Stratakis CA, Kirschner LS, Carney JA. Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab 2001; 86:4041-4046.
10. Stratakis CA, Bertherat J, Carney JA. Mutation of perinatal myosin heavy chain. N Engl J Med 2004; 351:2556-2558. In this 'Letter-to-the-Editor' it is stated that none of the patients with Carney Complex enrolled in the International Consortium has features of the 'variant' of the disease with mutations of the MYH 8 gene.
11. Carney JA, Stratakis CA. Epitheliod blue nevus and psammomatous melanotic schwannoma: The unusual pigmented skin tumors of the Carney complex. Sem Diag Path 1998; 15:216-224.
12. Stratakis CA, Papageorgiou T, Premkumar A, et al. Ovarian lesions in Carney complex: clinical genetics and possible predisposition to malignancy. J Clin Endocrinol Metab 2000; 85:4359-4366.
13. Stratakis CA, Courcoutsakis NA, Abati A, et al. Thyroid gland abnormalities in patients with the syndrome of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas (Carney complex). J Clin Endocrinol Metab 1997; 82:2037-2043.
14. Sandrini F, Matyakhina L, Sarlis NJ, et al. Regulatory subunit type 1-A of protein kinase A (PRKAR1A): A tumor suppressor gene for sporadic thyroid cancer. Genes Chromosomes Cancer 2002; 35:182-192.
15. Boikos SA, Stratakis CA. Pituitary pathology in patients with Carney complex: growth-hormone producing hyperplasia or tumors and their association with other abnormalities. Pituitary 2006 [Epub ahead of print].
16. Stratakis CA, Papageorgiou T. Ovarian tumors associated with multiple endocrine neoplasias and related syndromes (Carney complex, Peutz-Jeghers syndrome, von Hippel-Lindau disease, Cowden's disease). Int J Gynecol Cancer 2002; 12:337-347.
17. Tasken K, Skalhegg BS, Solberg R, et al. Novel isoenzymes of cAMP-dependent protein kinase exist in human cells due to formation of R1 alpha-R1beta heterodimeric complexes. J Biol Chem 1993; 268:21276-21283.
18. Scott JD. Cyclic nucleotide-dependent protein kinases. Pharmacol Ther 1991; 50:123-145.
19. Kirschner LS, Carney JA, Pack SD, et al. Mutations of the gene encoding the protein kinase A type I-A regulatory subunit in patients with the Carney complex. Nat Genet 2000; 26:89-92.
20. Horvath A, Boikos S, Weinberg W, et al. PRKAR1A mutations: Analysis of the largest database to date, identification of microdeletions and other novel disease-causing alterations, and functional characterization of expressed mutants. Annual Meeting of American Congress of Human Genetics, 17-18 August 2005, Salt Lake City, UT.
21. Fossberg TM, Doskeland SO, Ueland PM. Protein kinases in human renal cell carcinoma and renal cortex A comparison of isozyme distribution and of responsiveness to adenosine 3′:5′-cyclic monophosphate. Arch Biochem Biophys 1978; 189:272-281.
22. Handschin JC, Eppenberger U. Altered cellular ratio of type I and type II cyclic AMP-dependent protein kinase in human mammary tumors. FEBS Lett 1979;106:301-304.
23. Livesey SA, Kemp BE, Re CA, et al. Selective hormonal activation of cyclic AMP-dependent protein kinase isoenzymes in normal and malignant osteoblasts. J Biol Chem 1982; 257:14983-14987.
24. Nakajima F, Imashuku S, Wilimas J, et al. Distribution and properties of type I and type II binding proteins in the cyclic adenosine 3′:5′- monophosphate-dependent protein kinase system in Wilms' tumor. Cancer Res 1984;44:5182-5187.
25. Watson DM, Hawkins RA, Bundred NJ, et al. Tumor cyclic AMP binding proteins and endocrine responsiveness in patients with inoperable breast cancer. Br J Cancer 1987; 56:141-142.
26. Piroli G, Weisenberg LS, Grillo C, De Nicola AF. Subcellular distribution of cyclic adenosine 3′:5′-monophosphate-binding protein and estrogen receptors in control pituitaries and estrogen-induced pituitary tumors. J Natl Cancer Inst 1990; 82:596-601.
27. Bradbury AW, Carter DC, Miller WR, et al. Protein kinase A (PKA) regulatory subunit expression in colorectal cancer and related mucosa. Br J Cancer 1994; 69:738-742.
28. McDaid HM, Cairns MT, Atkinson RJ, et al. Increased expression of the RIalpha subunit of the cAMP-dependent protein kinase A is associated with advanced stage ovarian cancer. Br J Cancer 1999; 79:933-939.
29. Bossis I, Stratakis CA. PRKAR1A: Normal and abnormal functions. Endocrinology 2004; 145:5452-5458.
30. Griffin KJ, Kirschner LS, Matyakhina L, et al. Down-regulation of regulatory subunit type 1A of protein kinase A leads to endocrine and other tumors. Cancer Res 2004; 64:8811-8815.
31. Griffin KJ, Kirschner LS, Matyakhina L, et al. A transgenic mouse bearing an antisense construct of regulatory subunit type 1A of protein kinase A develops endocrine and other tumors: comparison to Carney complex and other PRKAR1A-induced lesions. J Med Genet 2004; 41:923-931. Animal model for Carney Complex.
32. Kirschner LS, Kusewitt DF, Matyakhina L, et al. A mouse model for the Carney complex tumor syndrome develops neoplasia in cyclic AMP-responsive tissues. Cancer Res 2005; 65:4506-4514. Another animal model for Carney Complex.
33. Amieux PS, Cummings DE, Motamed K, et al. Compensatory regulation of RIalpha protein levels in protein kinase A mutant mice. J Biol Chem 1997; 272:3993-3998.
34. Tsilou ET, Chan CC, Sandrini F, et al. Eyelid myxoma in Carney complex without PRKAR1A allelic loss. Am J Med Genet 2004; 130A:395-397.
35. Robinson-White A, Hundley TR, Shiferaw M, et al. Protein kinase A activity in PRKAR1A-mutant cells and regulation of mitogen-activated protein kinases ERK1/2. Hum Mol Genet 2003; 12:1475-1484.
36. Stratakis CA, Carney JA, Lin J-P, et al. Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2. J Clin Invest 1996; 97:699-705.
37. Kirschner LS, Sandrini F, Monbo J, et al. Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the Carney complex. Hum Mol Genet 2000; 9:3037-3046.
38. Horvath A, Boikos S, Giatzakis C, et al. A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia. Nat Genet 2006; 38:794-800. This is the first time that phosphodiesterases (PDEs) mutations are linked to adrenal hyperplasia. PDE11A codes for a dual specificity PDE that is expressed in adrenal cortex and is partially inhibited by taladafil (Cialis) and weakly by sildenafil (Viagra). These medications are widely used for the treatment of erectile dysfunction.
39. Nadella KS, Kirschner LS. Disruption of protein kinase a regulation causes immortalization and dysregulation of D-type cyclins. Cancer Res 2005; 65:10307-10315.